News search

Cardiovascular risk factors (particularly metabolic syndrome, insulin resistance, and diabetes) alter coronary microvascular function and increase the risk of atherosclerotic disease, which itself leads to changes in the coronary microcirculation.

Research

19 Sep 2024

JACC: Cardiovascular Imaging: Cardiometabolic risk factors in apparently healthy individuals are linked to altered coronary microcirculation

A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels' ability to regulate blood flow and predict future cardiovascular risk

Jesús Vázquez Cobos, Iván López-Montero, Enrique Calvo Alcocer, Pablo Hernansanz Agustín, Carmen Morales Vidal, José Antonio Enríquez, Rebeca Acín Pérez, Sara Jaroszewicz y José Luis Cabrera Alarcón.

Research

19 Sep 2024

Cell: Scientists at the CNIC discover an unexpected involvement of sodium transport in mitochondrial energy generation

The study, published in Cell, reveals an essential function of sodium transport in cellular energy generation

Research

13 Sep 2024

The RESILIENCE trial: preventing heart injury caused by anticancer drugs

RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors

About the CNIC

12 Sep 2024

Join CNIC through CURE HEART AND BRAIN (COFUND)

Research

9 Sep 2024

Circulation: A new mechanism of early-onset atherosclerosis in a premature aging syndrome

The new study, published in the journal Circulation, opens a new avenue of research into treatments for the atherosclerosis associated with progeria

About the CNIC

30 Aug 2024

Several studies led by the CNIC, informed recommendations included in the newly released 2024 ESC clinical practice guidelines (CPG)

About the CNIC

30 Aug 2024

Héctor Bueno receives the ESC President's Awards 2024 at the Congress of the European Society of Cardiology

Research

30 Aug 2024

Nature Medicine: CNIC scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine